Eiger BioPharmaceuticals Hosts New York Lunch to Discuss Latest PAH Treatments
Eiger BioPharmaceuticals will host a lunch May 10 in New York City to discuss the need for potential new mechanisms to treat pulmonary arterial hypertension (PAH). The event, to take place at the Lotte New York Palace Hotel, includes presentations by Stanford University’s Dr. Mark Nicolls and Dr. Roham Zamanian. Both…